Schott Doubles Production Capacity for Polymer Syringes - - BioPharm International

ADVERTISEMENT

Schott Doubles Production Capacity for Polymer Syringes


Schott installed a new line in its St. Gallen, Switzerland facility to manufacture small-size (1 to 10 mL), ready-to-fill syringes made of cyclic olefin copolymer (COC), the company noted in a press release. This expansion doubles Schott’s production capacity for COC syringes.

COC is an inert material that is compatible with a broad range of drugs. Schott says its syringes have excellent barrier properties and glass-like transparency and are break-resistant and lightweight. The syringes are manufactured in cleanrooms using a fully automated process from injection molding to the final packaging. The syringes are sterilized and are ready for aseptic-filling operations.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines

Click here